Rapid Micro Biosystems (RPID) Amortizatization of Intangibles (2020 - 2022)

Rapid Micro Biosystems (RPID) posted Amortizatization of Intangibles of $28000.0 for Q2 2022, up 566.67% sequentially from -$6000.0 in Q1 2022.

Rapid Micro Biosystems (RPID) Amortizatization of Intangibles (2020 - 2022) Analysis & Trends

Rapid Micro Biosystems has reported Amortizatization of Intangibles for 3 years, with the latest figure at $28000.0 in Q2 2022.

Quarterly Amortizatization of Intangibles changed N/A year-over-year to $28000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $21000.0 (changed N/A YoY) and the FY2021 annual result came in at $3000.0, changed N/A from the prior year.
Amortizatization of Intangibles advanced to $28000.0 in Q2 2022 per RPID's latest filing, from -$6000.0 in the prior quarter.
Over five years, Amortizatization of Intangibles peaked at $28000.0 in Q2 2022 and troughed at -$6000.0 in Q1 2022.
A 3-year average of $8750.0 and a median of $6500.0 in 2020 frame the typical range for Amortizatization of Intangibles.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Amortizatization of Intangibles (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	-
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	-
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	-
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	6.60 Mn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	-
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	-
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	-
10	Rapid Micro Biosystems	80.26 Mn	60.49 Mn	1.21 Mn	-

Download Data